Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Judith Regensteiner

Concepts (532)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Intermittent Claudication
46
2022
122
4.810
 Why?
Diabetes Mellitus, Type 2
55
2025
2602
4.290
 Why?
Sex Characteristics
18
2024
789
3.160
 Why?
Peripheral Arterial Disease
24
2022
509
3.120
 Why?
Exercise
47
2024
2205
2.970
 Why?
Exercise Therapy
31
2022
475
2.710
 Why?
Peripheral Vascular Diseases
25
2011
104
2.410
 Why?
Sex Factors
20
2024
2110
2.150
 Why?
Oxygen Consumption
33
2021
719
2.010
 Why?
Cardiovascular Diseases
23
2024
2191
1.870
 Why?
Walking
23
2022
545
1.820
 Why?
Diabetes Mellitus
18
2024
1101
1.770
 Why?
Women's Health
10
2024
316
1.730
 Why?
Biomedical Research
8
2024
719
1.360
 Why?
Exercise Test
38
2019
630
1.340
 Why?
Cardiology
6
2023
362
1.100
 Why?
Exercise Tolerance
15
2024
283
1.100
 Why?
American Heart Association
10
2019
358
1.070
 Why?
Quality of Life
18
2019
3211
0.990
 Why?
Leg
13
2021
242
0.980
 Why?
Research Personnel
5
2024
185
0.970
 Why?
Humans
185
2025
145785
0.870
 Why?
Mentoring
3
2022
166
0.820
 Why?
Adverse Drug Reaction Reporting Systems
1
2024
81
0.820
 Why?
United States Food and Drug Administration
1
2024
208
0.800
 Why?
Diabetic Angiopathies
6
2017
267
0.790
 Why?
Vascular Stiffness
3
2023
487
0.780
 Why?
Male
104
2025
73012
0.760
 Why?
Female
108
2025
79045
0.760
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
3
2024
444
0.740
 Why?
Muscle, Skeletal
14
2024
1791
0.730
 Why?
Cardiovascular System
5
2023
139
0.730
 Why?
Community Health Services
2
2015
231
0.720
 Why?
Diabetic Cardiomyopathies
3
2016
34
0.710
 Why?
Education, Medical
3
2020
276
0.700
 Why?
Periodicals as Topic
1
2024
209
0.700
 Why?
Insulin Resistance
12
2024
1244
0.650
 Why?
Cardiorespiratory Fitness
3
2025
74
0.640
 Why?
Lower Extremity
9
2019
450
0.630
 Why?
Interdisciplinary Research
1
2020
26
0.620
 Why?
Arterial Occlusive Diseases
7
2015
90
0.620
 Why?
Sitagliptin Phosphate
1
2019
31
0.590
 Why?
Endothelium, Vascular
6
2021
956
0.580
 Why?
Middle Aged
74
2025
36309
0.580
 Why?
Obesity
19
2023
3118
0.570
 Why?
Aged
57
2024
26217
0.570
 Why?
Diastole
1
2019
146
0.570
 Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2019
46
0.570
 Why?
Ventricular Dysfunction, Left
2
2025
394
0.560
 Why?
Surveys and Questionnaires
23
2018
6085
0.540
 Why?
Physical Fitness
9
2016
207
0.540
 Why?
Gender Identity
1
2019
129
0.530
 Why?
United States
37
2024
16126
0.520
 Why?
Hypertension
6
2022
1276
0.510
 Why?
Brachial Artery
6
2015
208
0.510
 Why?
Hypoglycemic Agents
9
2021
1399
0.500
 Why?
Metabolomics
2
2020
733
0.500
 Why?
Physical Exertion
7
2009
205
0.500
 Why?
Mitochondria, Muscle
4
2024
120
0.500
 Why?
Health Status
4
2020
835
0.500
 Why?
Blood Pressure
12
2021
1782
0.500
 Why?
Venoms
1
2016
22
0.490
 Why?
Vasodilator Agents
4
2010
330
0.480
 Why?
Curriculum
2
2020
1074
0.470
 Why?
Biomarkers
6
2024
4302
0.450
 Why?
Research Design
5
2024
1139
0.430
 Why?
Cardiac Rehabilitation
3
2019
46
0.420
 Why?
Life Style
9
2018
486
0.420
 Why?
Arteriosclerosis
5
2002
83
0.400
 Why?
National Institutes of Health (U.S.)
4
2023
148
0.400
 Why?
Physicians
5
2024
956
0.390
 Why?
Faculty, Medical
6
2024
305
0.380
 Why?
Sleep
1
2020
889
0.380
 Why?
Home Care Services
4
2019
284
0.370
 Why?
Microcirculation
4
2017
142
0.370
 Why?
Diabetes Mellitus, Type 1
9
2024
3937
0.360
 Why?
Risk Factors
29
2022
10919
0.360
 Why?
Advisory Committees
5
2019
229
0.360
 Why?
Mentors
4
2022
217
0.350
 Why?
Overweight
7
2025
614
0.350
 Why?
Blood Flow Velocity
4
2009
421
0.350
 Why?
Longevity
3
2024
178
0.350
 Why?
Adult
41
2025
40882
0.320
 Why?
Peptides
1
2016
1000
0.320
 Why?
Disability Evaluation
2
2011
311
0.320
 Why?
Ankle
3
2008
64
0.310
 Why?
Weight Loss
6
2016
859
0.310
 Why?
Gait
2
2006
312
0.300
 Why?
Treatment Outcome
24
2022
11794
0.300
 Why?
Regional Blood Flow
11
2020
514
0.290
 Why?
Tetrazoles
3
2006
50
0.290
 Why?
Cardiac Output, Low
1
2009
53
0.290
 Why?
Research Support as Topic
2
2020
81
0.280
 Why?
Physical Endurance
3
2011
279
0.280
 Why?
Thiazolidinediones
3
2010
143
0.280
 Why?
Double-Blind Method
8
2019
2064
0.270
 Why?
Ventricular Function, Left
2
2025
544
0.270
 Why?
Oxygen
4
2018
981
0.270
 Why?
Recovery of Function
9
2019
716
0.270
 Why?
Cost of Illness
3
2018
324
0.270
 Why?
Fear
1
2011
368
0.260
 Why?
Oxidative Phosphorylation
2
2019
209
0.260
 Why?
Glucagon-Like Peptide 1
2
2020
149
0.250
 Why?
Hematologic Agents
1
2006
3
0.250
 Why?
Follow-Up Studies
9
2024
5428
0.250
 Why?
Activities of Daily Living
5
2021
444
0.240
 Why?
Perception
1
2009
378
0.240
 Why?
Blood Glucose
10
2024
2344
0.240
 Why?
Stents
6
2015
564
0.240
 Why?
Medicare
2
2022
904
0.230
 Why?
Disease Management
4
2017
653
0.230
 Why?
Motor Activity
5
2012
718
0.230
 Why?
Myocardial Perfusion Imaging
1
2025
50
0.230
 Why?
Foundations
2
2018
27
0.220
 Why?
Vascular Diseases
4
2000
252
0.220
 Why?
Caregivers
3
2024
1074
0.220
 Why?
Predictive Value of Tests
6
2025
2123
0.220
 Why?
Pharmacovigilance
1
2024
24
0.220
 Why?
Interdisciplinary Studies
2
2017
30
0.220
 Why?
Vascular Surgical Procedures
5
2009
343
0.210
 Why?
Echocardiography
4
2018
648
0.210
 Why?
Troponin
1
2024
50
0.210
 Why?
Societies, Medical
3
2017
900
0.210
 Why?
Feasibility Studies
2
2022
1115
0.210
 Why?
Vasodilation
3
2015
521
0.210
 Why?
Troponin T
1
2024
63
0.210
 Why?
Respiration
3
1990
207
0.210
 Why?
Magnetic Resonance Imaging, Cine
1
2025
214
0.210
 Why?
Troponin I
1
2024
73
0.200
 Why?
Heart Rate
6
2015
856
0.200
 Why?
Fibrinolysis
2
2003
164
0.200
 Why?
Kinetics
5
2015
1568
0.200
 Why?
Insulin
5
2020
2516
0.200
 Why?
Medroxyprogesterone
4
1991
11
0.200
 Why?
Pulse Wave Analysis
3
2023
267
0.200
 Why?
Chest Pain
1
2024
99
0.200
 Why?
Muscles
7
1994
330
0.190
 Why?
Lung Diseases
3
2019
782
0.190
 Why?
Iliac Artery
2
2014
55
0.190
 Why?
Polyhydroxyethyl Methacrylate
1
2002
10
0.190
 Why?
Minority Groups
2
2022
285
0.190
 Why?
Financing, Organized
2
2020
36
0.190
 Why?
Financial Management
1
2022
16
0.190
 Why?
Phosphodiesterase Inhibitors
1
2002
73
0.180
 Why?
Glucose Intolerance
1
2024
142
0.180
 Why?
Vitamin E
1
2003
125
0.180
 Why?
Case-Control Studies
8
2025
3634
0.180
 Why?
Orthopedics
1
2024
175
0.170
 Why?
Estrogens, Conjugated (USP)
3
1991
52
0.170
 Why?
Organizational Innovation
2
2020
119
0.170
 Why?
Congresses as Topic
2
2020
224
0.170
 Why?
Endovascular Procedures
2
2018
390
0.170
 Why?
Arginine
1
2003
264
0.170
 Why?
Placebos
3
2019
193
0.170
 Why?
Ascorbic Acid
1
2003
184
0.170
 Why?
Academic Medical Centers
3
2020
554
0.170
 Why?
Adiponectin
2
2016
242
0.170
 Why?
Severity of Illness Index
4
2009
2933
0.160
 Why?
Sulfonylurea Compounds
2
2019
51
0.160
 Why?
Echocardiography, Doppler
3
2016
115
0.160
 Why?
Interdisciplinary Communication
2
2020
201
0.160
 Why?
Sex Distribution
2
2020
388
0.160
 Why?
Cross-Sectional Studies
9
2025
5925
0.160
 Why?
Neovascularization, Physiologic
2
2012
193
0.160
 Why?
Qualitative Research
3
2024
1683
0.160
 Why?
Cardiovascular Agents
2
2014
166
0.160
 Why?
Precision Medicine
2
2024
461
0.150
 Why?
Patient Compliance
4
2015
588
0.150
 Why?
Time Factors
11
2018
7134
0.150
 Why?
Arteries
3
2016
261
0.150
 Why?
Forearm
2
2015
141
0.150
 Why?
Hemodynamics
6
2009
1118
0.150
 Why?
Clinical Trials as Topic
6
2019
1062
0.140
 Why?
Body Composition
5
2014
693
0.140
 Why?
Pediatric Obesity
2
2017
638
0.140
 Why?
Randomized Controlled Trials as Topic
7
2006
1752
0.140
 Why?
Telerehabilitation
1
2019
49
0.140
 Why?
Body Mass Index
9
2017
2447
0.140
 Why?
Adolescent
12
2022
22577
0.140
 Why?
Cause of Death
1
2020
472
0.130
 Why?
Women's Rights
1
2017
4
0.130
 Why?
Diabetes Complications
4
2010
225
0.130
 Why?
Leadership
2
2020
402
0.130
 Why?
Pentoxifylline
3
2006
23
0.130
 Why?
Magnetic Resonance Spectroscopy
2
2024
627
0.130
 Why?
Health Status Indicators
4
2015
167
0.130
 Why?
Burnout, Professional
1
2024
488
0.130
 Why?
Program Development
1
2019
368
0.130
 Why?
Resistance Training
1
2020
186
0.130
 Why?
Sexism
1
2018
68
0.130
 Why?
Heart Diseases
2
2019
341
0.130
 Why?
Aged, 80 and over
9
2012
8347
0.120
 Why?
Death, Sudden, Cardiac
1
2018
237
0.120
 Why?
Colorado
9
2017
4556
0.120
 Why?
Ankle Brachial Index
2
2014
41
0.120
 Why?
Interviews as Topic
4
2024
916
0.120
 Why?
Circadian Rhythm
2
2020
513
0.120
 Why?
Capillaries
3
2012
125
0.120
 Why?
Microvessels
1
2017
97
0.120
 Why?
Glucose Tolerance Test
4
2024
361
0.110
 Why?
Blood Vessels
1
2017
167
0.110
 Why?
Faculty
1
2017
148
0.110
 Why?
Reference Values
4
2007
798
0.110
 Why?
Ischemia
1
2019
422
0.110
 Why?
Leptin
1
2017
248
0.110
 Why?
Plethysmography
3
2011
104
0.110
 Why?
Adiposity
2
2017
532
0.110
 Why?
Practice Guidelines as Topic
3
2019
1582
0.110
 Why?
Intention to Treat Analysis
1
2015
79
0.110
 Why?
Program Evaluation
2
2020
944
0.110
 Why?
Needs Assessment
1
2018
403
0.110
 Why?
Myocardium
1
2020
935
0.110
 Why?
Ventricular Function
1
2015
53
0.110
 Why?
Health Status Disparities
1
2018
321
0.110
 Why?
Cardiac Output
1
2015
179
0.110
 Why?
Physical Education and Training
1
1994
70
0.110
 Why?
Endothelium
1
2015
119
0.100
 Why?
Arterial Pressure
1
2015
134
0.100
 Why?
Oxidative Stress
1
2021
1361
0.100
 Why?
Healthy Volunteers
1
2015
219
0.100
 Why?
Pilot Projects
2
2015
1898
0.100
 Why?
Peripheral Nervous System Diseases
1
1995
134
0.100
 Why?
Hyperlipidemias
3
2004
120
0.100
 Why?
Patient Selection
4
2019
739
0.100
 Why?
Diagnostic Self Evaluation
1
2013
24
0.100
 Why?
Health Care Costs
2
2014
425
0.100
 Why?
Angioplasty
2
2009
50
0.100
 Why?
Hypoxia
3
1990
1199
0.100
 Why?
Aortic Diseases
1
2014
125
0.100
 Why?
Menopause
3
1991
326
0.090
 Why?
Reaction Time
1
2015
434
0.090
 Why?
Diet, Reducing
1
2013
91
0.090
 Why?
Carnitine
5
2001
91
0.090
 Why?
Smoking
6
2010
1477
0.090
 Why?
Diabetic Nephropathies
2
2014
322
0.090
 Why?
Capacity Building
1
2012
62
0.090
 Why?
Premenopause
2
2003
125
0.090
 Why?
Students, Medical
1
2017
378
0.090
 Why?
Counseling
1
2015
401
0.090
 Why?
Heart Ventricles
1
2016
756
0.090
 Why?
Myocardial Revascularization
1
2011
85
0.090
 Why?
Kidney
2
2021
1497
0.080
 Why?
Linear Models
2
2014
849
0.080
 Why?
Research Report
1
2011
86
0.080
 Why?
Clinical Protocols
1
1993
280
0.080
 Why?
Consensus
3
2019
479
0.080
 Why?
Retrospective Studies
4
2024
17330
0.080
 Why?
Benchmarking
1
2012
191
0.080
 Why?
Health Promotion
1
2017
775
0.080
 Why?
Fatty Acids, Nonesterified
2
2009
154
0.080
 Why?
Sickness Impact Profile
1
2011
62
0.080
 Why?
Comorbidity
4
2021
1662
0.080
 Why?
Hyperemia
1
2011
49
0.080
 Why?
Self Concept
1
2012
254
0.080
 Why?
Hemoglobins
2
2017
386
0.080
 Why?
Coronary Disease
4
2004
382
0.080
 Why?
Atherosclerosis
2
2011
409
0.080
 Why?
Niacin
1
2010
16
0.080
 Why?
Lovastatin
1
2010
37
0.080
 Why?
Hypertrophy, Left Ventricular
2
2009
124
0.080
 Why?
Affect
1
2012
321
0.080
 Why?
C-Reactive Protein
2
2009
423
0.080
 Why?
Young Adult
6
2024
14254
0.070
 Why?
Body Fat Distribution
1
2009
46
0.070
 Why?
Gonadal Steroid Hormones
1
1990
143
0.070
 Why?
Vascular Endothelial Growth Factor A
1
2012
552
0.070
 Why?
Platelet Aggregation Inhibitors
3
2002
499
0.070
 Why?
Heart Function Tests
1
2009
59
0.070
 Why?
Hyperinsulinism
2
2010
115
0.070
 Why?
Pulmonary Wedge Pressure
1
2009
67
0.070
 Why?
Thinness
1
2009
100
0.070
 Why?
Analysis of Variance
4
2012
1300
0.070
 Why?
Fasting
2
2005
279
0.070
 Why?
Psychometrics
1
2012
732
0.070
 Why?
Aorta
1
2011
442
0.070
 Why?
Age Factors
4
2021
3346
0.070
 Why?
Heart Failure
3
2018
2326
0.070
 Why?
Hospitalization
1
2018
2461
0.070
 Why?
Puberty
1
2009
137
0.070
 Why?
Myoglobin
1
2007
12
0.070
 Why?
Perfusion
1
2009
251
0.070
 Why?
Angina Pectoris
1
2008
76
0.070
 Why?
Cost-Benefit Analysis
4
2014
644
0.060
 Why?
Leisure Activities
2
2006
31
0.060
 Why?
Mitochondria
1
2014
994
0.060
 Why?
Inflammation
3
2009
2885
0.060
 Why?
Awareness
1
2008
110
0.060
 Why?
Aging
1
2018
1973
0.060
 Why?
Regression Analysis
5
1998
1001
0.060
 Why?
Prospective Studies
8
2019
8078
0.060
 Why?
Health Knowledge, Attitudes, Practice
2
2008
1420
0.060
 Why?
Prevalence
3
2019
2875
0.060
 Why?
Dyspnea
1
2008
250
0.060
 Why?
Chronic Disease
2
2023
1812
0.060
 Why?
Blood Viscosity
2
1995
19
0.060
 Why?
Metformin
2
2010
329
0.060
 Why?
Glycation End Products, Advanced
1
2006
81
0.060
 Why?
Pulmonary Circulation
1
2007
430
0.060
 Why?
Glucose Clamp Technique
1
2005
199
0.050
 Why?
Hematocrit
2
1995
108
0.050
 Why?
Interleukin-6
1
2009
780
0.050
 Why?
Sulfonic Acids
1
2004
14
0.050
 Why?
Guilt
1
2024
10
0.050
 Why?
Multicenter Studies as Topic
2
2004
413
0.050
 Why?
Neoplasms
2
2010
2913
0.050
 Why?
Nutrition Surveys
1
2006
279
0.050
 Why?
Animals
5
2018
38106
0.050
 Why?
Population Dynamics
1
1985
142
0.050
 Why?
Acetates
1
2004
78
0.050
 Why?
Work-Life Balance
1
2024
22
0.050
 Why?
Estrogens
2
2010
367
0.050
 Why?
Lipids
1
2009
707
0.050
 Why?
Health Maintenance Organizations
1
2004
105
0.050
 Why?
Biopsy
3
2012
1082
0.050
 Why?
Incidence
3
2019
2934
0.050
 Why?
Cohort Studies
3
2016
6033
0.050
 Why?
Body Weight
2
2006
972
0.050
 Why?
Dietary Carbohydrates
1
2004
147
0.050
 Why?
Mitochondrial Diseases
1
2024
92
0.050
 Why?
Physicians, Women
1
2024
90
0.050
 Why?
Intracranial Arterial Diseases
1
2002
8
0.050
 Why?
Genetic Vectors
1
2004
335
0.050
 Why?
Dietary Fats
1
2004
308
0.050
 Why?
Neovascularization, Pathologic
1
2004
287
0.050
 Why?
Child
5
2017
22740
0.050
 Why?
Serum Globulins
1
2002
5
0.050
 Why?
Glycolysis
1
2024
340
0.050
 Why?
Musculoskeletal Diseases
1
2003
91
0.040
 Why?
Genetic Therapy
1
2004
316
0.040
 Why?
Psychomotor Performance
1
2004
324
0.040
 Why?
Plasminogen Activator Inhibitor 1
1
2002
85
0.040
 Why?
Prognosis
2
2010
4330
0.040
 Why?
Lung
1
2015
4116
0.040
 Why?
Single-Blind Method
2
2013
318
0.040
 Why?
Pelvis
1
2002
125
0.040
 Why?
Proteinuria
1
2001
104
0.040
 Why?
Fibroblast Growth Factor 2
1
2001
94
0.040
 Why?
Diet
2
2010
1278
0.040
 Why?
Homocysteine
1
2002
152
0.040
 Why?
Adipose Tissue
1
2005
645
0.040
 Why?
Physical Examination
1
2002
244
0.040
 Why?
Enzyme Inhibitors
1
2004
821
0.040
 Why?
Alcohol Drinking
2
2010
843
0.040
 Why?
Meta-Analysis as Topic
1
2002
173
0.040
 Why?
Ambulatory Care
2
2014
610
0.040
 Why?
Patient Satisfaction
2
2002
712
0.040
 Why?
Fibrinogen
1
2002
180
0.040
 Why?
Altitude
1
1985
463
0.040
 Why?
Multivariate Analysis
3
2014
1547
0.040
 Why?
Cardiovascular Surgical Procedures
1
2000
30
0.040
 Why?
Aorta, Thoracic
1
2023
288
0.040
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2002
229
0.040
 Why?
Cholesterol, LDL
2
2014
360
0.040
 Why?
Administration, Oral
1
2003
867
0.040
 Why?
Carrier Proteins
1
2004
729
0.040
 Why?
Tissue Plasminogen Activator
1
2002
248
0.040
 Why?
Myocardial Ischemia
1
2002
285
0.040
 Why?
Medroxyprogesterone Acetate
2
1990
33
0.040
 Why?
Organization and Administration
1
2019
14
0.040
 Why?
Specialties, Surgical
1
2000
82
0.040
 Why?
Internal Medicine
1
2002
279
0.040
 Why?
Femoral Artery
2
2011
190
0.040
 Why?
Pregnancy
3
2020
7216
0.040
 Why?
Apoptosis
1
2007
2445
0.040
 Why?
Sports Medicine
2
2010
119
0.040
 Why?
Asia
1
2018
70
0.040
 Why?
Risk Adjustment
1
2019
85
0.040
 Why?
Densitometry
1
1998
36
0.030
 Why?
Lactic Acid
2
1998
295
0.030
 Why?
Patient Outcome Assessment
1
2019
130
0.030
 Why?
Hypercapnia
2
1989
53
0.030
 Why?
Coronary Vessels
1
2020
246
0.030
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2001
346
0.030
 Why?
Rural Population
2
1995
661
0.030
 Why?
Walking Speed
1
2018
53
0.030
 Why?
Cell Respiration
1
2018
105
0.030
 Why?
Autonomic Nervous System
1
1998
83
0.030
 Why?
Public Health
1
2023
574
0.030
 Why?
Smoking Cessation
1
2002
441
0.030
 Why?
Secondary Prevention
1
2019
251
0.030
 Why?
Walk Test
1
2018
82
0.030
 Why?
Family Practice
1
2001
407
0.030
 Why?
Hand Strength
1
2018
144
0.030
 Why?
Drug Therapy, Combination
2
2010
1043
0.030
 Why?
Social Stigma
1
2020
173
0.030
 Why?
Neural Conduction
2
1995
92
0.030
 Why?
Capillary Resistance
1
2017
4
0.030
 Why?
Career Choice
1
2019
235
0.030
 Why?
Oxyhemoglobins
1
2017
28
0.030
 Why?
Betacoronavirus
1
2020
289
0.030
 Why?
Acute Disease
1
2020
1036
0.030
 Why?
Pragmatic Clinical Trials as Topic
1
2017
133
0.030
 Why?
Caloric Restriction
1
2018
133
0.030
 Why?
Depression
1
2007
1559
0.030
 Why?
Reproducibility of Results
2
2013
3418
0.030
 Why?
Weight Reduction Programs
1
2018
140
0.030
 Why?
Spectroscopy, Near-Infrared
1
2017
70
0.030
 Why?
Canada
1
2018
432
0.030
 Why?
Heart
1
2020
626
0.030
 Why?
Bicycling
1
2017
117
0.030
 Why?
Forecasting
2
2000
390
0.030
 Why?
Sensitivity and Specificity
2
2013
2000
0.030
 Why?
Vascular Resistance
1
2017
370
0.030
 Why?
Social Support
1
2020
651
0.030
 Why?
Matched-Pair Analysis
1
1995
37
0.030
 Why?
Stroke Volume
1
2018
655
0.030
 Why?
Pneumonia, Viral
1
2020
391
0.030
 Why?
Coronavirus Infections
1
2020
384
0.030
 Why?
Risk
1
2017
923
0.030
 Why?
Absorptiometry, Photon
1
2016
277
0.030
 Why?
Energy Intake
3
2006
512
0.030
 Why?
Electrophysiology
1
1995
218
0.030
 Why?
Cystatin C
1
2014
66
0.030
 Why?
Vascular Patency
1
2014
121
0.030
 Why?
Quality-Adjusted Life Years
1
2014
125
0.030
 Why?
Models, Economic
1
2014
62
0.030
 Why?
Phosphorus
1
2014
90
0.030
 Why?
Life Expectancy
1
2014
73
0.030
 Why?
Patient Education as Topic
1
2019
777
0.030
 Why?
Hospital Costs
1
2014
125
0.030
 Why?
Stress, Mechanical
1
2016
494
0.030
 Why?
Constriction, Pathologic
1
2014
249
0.020
 Why?
Databases, Factual
2
2011
1491
0.020
 Why?
Health Behavior
1
2019
791
0.020
 Why?
Drug Costs
1
2014
117
0.020
 Why?
Cyclic AMP Response Element-Binding Protein
1
2014
146
0.020
 Why?
Health Education
1
2016
346
0.020
 Why?
Nitric Oxide Synthase Type III
1
2014
203
0.020
 Why?
Collateral Circulation
2
2003
20
0.020
 Why?
Evidence-Based Medicine
1
2016
740
0.020
 Why?
Creatinine
1
2014
515
0.020
 Why?
Administrative Personnel
1
2012
33
0.020
 Why?
Carotid Stenosis
1
2014
107
0.020
 Why?
Statistics as Topic
1
2013
283
0.020
 Why?
Biomechanical Phenomena
1
2016
860
0.020
 Why?
Blood Vessel Prosthesis
1
2013
140
0.020
 Why?
Waist Circumference
1
2012
143
0.020
 Why?
Treatment Failure
1
2013
360
0.020
 Why?
Health Planning
1
1992
47
0.020
 Why?
North Carolina
1
2012
130
0.020
 Why?
Internship and Residency
1
2002
1269
0.020
 Why?
Pandemics
1
2020
1711
0.020
 Why?
Vascular Endothelial Growth Factor Receptor-1
1
2012
74
0.020
 Why?
Muscle Contraction
1
2014
429
0.020
 Why?
Muscle Strength
1
2014
332
0.020
 Why?
Popliteal Artery
1
2011
62
0.020
 Why?
Cerebrovascular Disorders
1
1992
105
0.020
 Why?
Estrone
1
1991
41
0.020
 Why?
Radioimmunoassay
1
1991
165
0.020
 Why?
Behavior Therapy
1
2014
296
0.020
 Why?
Glomerular Filtration Rate
1
2014
765
0.020
 Why?
Follicular Phase
1
1990
41
0.020
 Why?
Kaplan-Meier Estimate
1
2013
971
0.020
 Why?
Metabolism
1
1990
44
0.020
 Why?
Luteal Phase
1
1990
51
0.020
 Why?
C-Peptide
1
1991
190
0.020
 Why?
Incretins
1
2010
21
0.020
 Why?
Receptor, IGF Type 1
1
2010
64
0.020
 Why?
Receptor, Insulin
1
2010
93
0.020
 Why?
Health Services Research
1
2012
391
0.020
 Why?
Acetylcarnitine
1
1989
6
0.020
 Why?
Adaptation, Physiological
1
2014
560
0.020
 Why?
Actigraphy
1
2010
148
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2012
849
0.020
 Why?
Progesterone
1
1991
215
0.020
 Why?
Percutaneous Coronary Intervention
1
2015
549
0.020
 Why?
Delayed-Action Preparations
1
2010
189
0.020
 Why?
Risk Assessment
2
2009
3752
0.020
 Why?
Respiration Disorders
1
1989
78
0.020
 Why?
Attitude of Health Personnel
1
2017
1197
0.020
 Why?
Partial Pressure
1
1988
30
0.020
 Why?
Energy Metabolism
3
2006
935
0.020
 Why?
Estradiol
1
1991
515
0.020
 Why?
Drug Interactions
1
1989
405
0.020
 Why?
Tidal Volume
1
1988
109
0.020
 Why?
Pain
1
1993
791
0.020
 Why?
Ankle Joint
1
2008
123
0.020
 Why?
Risk Reduction Behavior
1
2009
217
0.020
 Why?
Fluoroquinolones
1
2007
44
0.020
 Why?
Caspase 3
1
2007
242
0.020
 Why?
Models, Cardiovascular
1
2007
196
0.020
 Why?
Receptor for Advanced Glycation End Products
1
2006
33
0.010
 Why?
Hyperglycemia
1
2010
381
0.010
 Why?
Testosterone
1
2010
416
0.010
 Why?
Longitudinal Studies
1
2014
2968
0.010
 Why?
Carbon Dioxide
1
1988
227
0.010
 Why?
Enzyme Activation
1
2007
762
0.010
 Why?
Income
1
2007
203
0.010
 Why?
Receptors, Immunologic
1
2006
209
0.010
 Why?
Sterol O-Acyltransferase
1
2004
6
0.010
 Why?
Sleep Wake Disorders
1
1989
314
0.010
 Why?
Acetamides
1
2004
41
0.010
 Why?
Case Management
1
2004
68
0.010
 Why?
Age Distribution
1
2004
404
0.010
 Why?
Cell Adhesion Molecules
1
2004
181
0.010
 Why?
Calcium-Binding Proteins
1
2004
221
0.010
 Why?
Gene Transfer Techniques
1
2004
187
0.010
 Why?
Intercellular Signaling Peptides and Proteins
1
2004
376
0.010
 Why?
Cognition Disorders
1
2007
544
0.010
 Why?
Cytokines
1
2010
2069
0.010
 Why?
Magnetic Resonance Imaging
1
2014
3916
0.010
 Why?
Endpoint Determination
1
2001
85
0.010
 Why?
Lactates
2
1992
82
0.010
 Why?
Ultrasonography, Doppler
1
2001
126
0.010
 Why?
World Health Organization
1
2000
104
0.010
 Why?
Attitude
1
2002
259
0.010
 Why?
Sulfonamides
1
2004
583
0.010
 Why?
Wound Healing
1
2003
355
0.010
 Why?
Algorithms
1
2008
1851
0.010
 Why?
Costs and Cost Analysis
1
2000
221
0.010
 Why?
Artificial Limbs
1
2003
214
0.010
 Why?
Indians, North American
1
2004
598
0.010
 Why?
Models, Biological
1
2006
1764
0.010
 Why?
Logistic Models
1
2004
2139
0.010
 Why?
Interpersonal Relations
1
2002
400
0.010
 Why?
Socioeconomic Factors
1
2002
1327
0.010
 Why?
Models, Theoretical
1
2000
560
0.010
 Why?
Diabetic Neuropathies
1
1998
100
0.010
 Why?
Diabetic Retinopathy
1
1998
211
0.010
 Why?
Muscle Fibers, Skeletal
1
1996
212
0.010
 Why?
Rehabilitation
1
1992
20
0.010
 Why?
Cholesterol, HDL
1
1991
201
0.000
 Why?
Hydroxybutyrates
1
1989
15
0.000
 Why?
3-Hydroxybutyric Acid
1
1989
17
0.000
 Why?
Electromyography
1
1992
419
0.000
 Why?
Blood Gas Analysis
1
1989
82
0.000
 Why?
Ultrasonics
1
1989
50
0.000
 Why?
Nervous System Diseases
1
1992
286
0.000
 Why?
Action Potentials
1
1992
502
0.000
 Why?
Sleep Apnea Syndromes
1
1989
98
0.000
 Why?
Drug Combinations
1
1989
396
0.000
 Why?
Mice
1
1989
18358
0.000
 Why?
Regensteiner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (532) concept(s)
_
Co-Authors Expand Description
See all (52) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)